Based on molecular markers such as the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), breast cancer can be classified into three main subtypes: hormone receptor (HR)-positive, HER2-positive, and triple-negative breast cancer (TNBC). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.